Pamir M N, Ozduman K, Belirgen M, Kilic T, Ozek M M
Faculty of Medicine, Department of Neurosurgery, Marmara University, Istanbul, Turkey.
Acta Neurochir (Wien). 2005 Nov;147(11):1121-30; discussion 1130. doi: 10.1007/s00701-005-0625-0. Epub 2005 Sep 1.
Current literature on tuberculum sellae meningiomas is very heterogenous due to wide variation in nomenclature, diagnostic and operative techniques. The aim of this study is specifically to analyze the results of pterional craniotomy for tuberculum sellae meningiomas. A homogenous cohort of 42 consecutively operated tuberculum sellae meningioma cases are reviewed with special emphasis on the effects of pterional microsurgery on visual outcome.
This is a retrospective clinical analysis. 42 consecutive patients operated upon during the period of 15 years in a single institution using standard imaging protocols and pterional microsurgery are presented and effect of various variables on visual outcome analysed.
81% of the patients presented with visual symptoms. The mean duration of symptoms was 12 months. Tumour volumes ranged from 7.5 to 210 mm(3). A right sided pterional microsurgery was used in all patients. Complete resection rate was 81%. Vision improved in 58%, worsened in 14%. Non-visual morbidity was 7.1% and mortality was 2.4%. The follow up period of patients ranged from 3 to 192 months (median: 30 months). The mean was 37.5 months (SD = +/-36.7 months) and a recurrence rate of 2.4% was observed.
A standard pterional craniotomy using microsurgical technique provides the necessary exposure enabling total removal while keeping the complications to a minimum. Upon analysis of our findings we found that patient age of more than 60, duration of visual symptoms longer than 1 year, severe visual symptomatology, predominantly vertical growth, presence of significant peri-tumoural oedema, absence of an intact arachnoid plane and subtotal removal were correlated with a dismal visual outcome.
由于命名、诊断和手术技术差异很大,目前关于鞍结节脑膜瘤的文献非常混杂。本研究的目的是专门分析经翼点入路开颅手术治疗鞍结节脑膜瘤的结果。回顾了42例连续接受手术的鞍结节脑膜瘤病例,特别强调翼点显微手术对视力结果的影响。
这是一项回顾性临床分析。介绍了在15年期间于单一机构接受标准影像检查和翼点显微手术的42例连续患者,并分析了各种变量对视力结果的影响。
81%的患者有视觉症状。症状的平均持续时间为12个月。肿瘤体积范围为7.5至210立方毫米。所有患者均采用右侧翼点显微手术。完全切除率为81%。视力改善的患者占58%,恶化的占14%。非视觉并发症发生率为7.1%,死亡率为2.4%。患者的随访期为3至192个月(中位数:30个月)。平均为37.5个月(标准差=±36.7个月),观察到复发率为2.4%。
采用显微手术技术的标准翼点开颅术可提供必要的暴露,实现全切,同时将并发症降至最低。通过对我们的研究结果进行分析,我们发现年龄超过60岁、视觉症状持续时间超过1年、严重视觉症状、主要为垂直生长、肿瘤周围有明显水肿、没有完整的蛛网膜平面以及次全切除与不良的视力结果相关。